Loading chat...
NY A00582
Bill
Status
1/9/2023
Primary Sponsor
John McDonald
Click for details
AI Summary
-
Prohibits step therapy protocols from applying to medically necessary prescription drugs in seven therapeutic classes: dermatologic, hematology, ophthalmologic, rheumatic, gastrointestinal, neurology, and oncology.
-
Exempts non-formulary drugs in these therapeutic classes from step therapy requirements.
-
Applies the restriction to both insurance law (Section 4902) and public health law (Section 4902) utilization review agents.
-
Takes effect immediately upon enactment.
Legislative Description
Ensures that step therapy shall not apply to medically necessary prescription drugs in the dermatologic, hematology, ophthalmologic, rheumatic, gastrointestinal, neurology, and oncology therapeutic classes, including non-formulary drugs.
Last Action
referred to insurance
1/3/2024